Sirinya Teeraananchai1,2, Suchada Chaivooth3, Stephen J Kerr1,2,4, Sorakij Bhakeecheep3, Anchalee Avihingsanon1,5, Achara Teeraratkul6, Petchsri Sirinirund7, Matthew G Law2, Kiat Ruxrungtham1,5. 1. HIV-NAT, Thai Red Cross AIDS Research Centre, Bangkok, Thailand. 2. Kirby Institute, University of New South Wales, Sydney, Australia. 3. The HIV/AIDS, Tuberculosis and Infectious Diseases Program, National Health Security Office (NHSO), Bangkok, Thailand. 4. Department of Global Health, Academic Medical Center, University of Amsterdam, Amsterdam Institute of Global Health and Development, Amsterdam, the Netherlands. 5. Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand. 6. Thailand MOPH - US CDC Collaboration, Nonthaburi, Thailand. 7. Ministry of Public Health, Nonthaburi, Thailand.
Abstract
BACKGROUND: Access to combination antiretroviral therapy (cART) has decreased mortality in HIV-positive people. We aimed to estimate the expected additional years of life in HIV-positive Thai people after starting cART through the National AIDS Program (NAP), administered by the Thai National Health Security Office (NHSO). METHODS: The NHSO database collects characteristics of all Thai HIV-infected patients through the National AIDS Program, including linkage with the National Death Registry for vital status. This study included patients aged ≥15 years at cART initiation between 2008 and 2014. The abridged life table method was used to construct life tables stratified by sex and baseline CD4+ T-cell count. Life expectancy was defined as the additional years of life from age at starting cART. RESULTS: 201,688 eligible patients were included in analyses, contributing 618,837 person-years of follow-up. Median CD4+ T-cell count was 109 cells/mm3 and median age 37 years. The overall life expectancy after cART initiation at age 20 was 25.4 (95% CI, 25.3, 25.6) years and 20.6 (95% CI, 20.5, 20.7) at age 35 years. Life expectancy at baseline CD4+ T-cell count ≥350 cells/mm3 was 51.9 (95% CI, 51.0, 52.9) years for age 20 years and 43.2 (95% CI, 42.4, 44.1) years for age 35 years, close to life expectancy in the general Thai population. CONCLUSIONS: Increasing life expectancy with higher baseline CD4+ T-cell counts supports the guideline recommendations to start cART irrespective of CD4+ T-cell count. These results are beneficial to forecast the treatment cost and develop health policies for people living with HIV in Thailand and Asia.
BACKGROUND: Access to combination antiretroviral therapy (cART) has decreased mortality in HIV-positive people. We aimed to estimate the expected additional years of life in HIV-positive Thai people after starting cART through the National AIDS Program (NAP), administered by the Thai National Health Security Office (NHSO). METHODS: The NHSO database collects characteristics of all Thai HIV-infectedpatients through the National AIDS Program, including linkage with the National Death Registry for vital status. This study included patients aged ≥15 years at cART initiation between 2008 and 2014. The abridged life table method was used to construct life tables stratified by sex and baseline CD4+ T-cell count. Life expectancy was defined as the additional years of life from age at starting cART. RESULTS: 201,688 eligible patients were included in analyses, contributing 618,837 person-years of follow-up. Median CD4+ T-cell count was 109 cells/mm3 and median age 37 years. The overall life expectancy after cART initiation at age 20 was 25.4 (95% CI, 25.3, 25.6) years and 20.6 (95% CI, 20.5, 20.7) at age 35 years. Life expectancy at baseline CD4+ T-cell count ≥350 cells/mm3 was 51.9 (95% CI, 51.0, 52.9) years for age 20 years and 43.2 (95% CI, 42.4, 44.1) years for age 35 years, close to life expectancy in the general Thai population. CONCLUSIONS: Increasing life expectancy with higher baseline CD4+ T-cell counts supports the guideline recommendations to start cART irrespective of CD4+ T-cell count. These results are beneficial to forecast the treatment cost and develop health policies for people living with HIV in Thailand and Asia.
Authors: Leigh F Johnson; Nanina Anderegg; Elizabeth Zaniewski; Jeffrey W Eaton; Peter F Rebeiro; Gabriela Carriquiry; Denis Nash; Marcel Yotebieng; Didier K Ekouevi; Charles B Holmes; Jun Y Choi; Awachana Jiamsakul; Giorgos Bakoyannis; Keri N Althoff; Annette H Sohn; Constantin Yiannoutsos; Matthias Egger Journal: AIDS Date: 2019-12-15 Impact factor: 4.177
Authors: Hailong Li; Kristen A McLaurin; Charles F Mactutus; Benjamin Likins; Wenfei Huang; Sulie L Chang; Rosemarie M Booze Journal: Viruses Date: 2022-06-10 Impact factor: 5.818
Authors: Françoise Barré-Sinoussi; Salim S Abdool Karim; Jan Albert; Linda-Gail Bekker; Chris Beyrer; Pedro Cahn; Alexandra Calmy; Beatriz Grinsztejn; Andrew Grulich; Adeeba Kamarulzaman; Nagalingeswaran Kumarasamy; Mona R Loutfy; Kamal M El Filali; Souleymane Mboup; Julio Sg Montaner; Paula Munderi; Vadim Pokrovsky; Anne-Mieke Vandamme; Benjamin Young; Peter Godfrey-Faussett Journal: J Int AIDS Soc Date: 2018-07 Impact factor: 5.396